{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:33:12Z","timestamp":1793406792250,"version":"4.5.0"},"reference-count":108,"publisher":"Xia & He Publishing","issue":"1","license":[{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["www.xiahepublishing.com"],"crossmark-restriction":false},"short-container-title":["J Clin Transl Hepatol"],"published-print":{"date-parts":[[2022,2,28]]},"DOI":"10.14218\/jcth.2021.00171","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T22:43:02Z","timestamp":1632264182000},"page":"164-173","update-policy":"https:\/\/doi.org\/10.14218\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Influence of Nonalcoholic Fatty Liver Disease on the Occurrence and Severity of Chronic Kidney Disease"],"prefix":"10.14218","volume":"10","author":[{"given":"Ziwen","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoquan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8153-3754","authenticated-orcid":false,"given":"Yanjing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"issue":"2 Suppl 1","key":"key20210921224256_JCTH-D-21-00171-b1","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"key20210921224256_JCTH-D-21-00171-b2","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"key20210921224256_JCTH-D-21-00171-b3","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"issue":"5","key":"key20210921224256_JCTH-D-21-00171-b4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2036.2010.04556.x","article-title":"Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"33","author":"Dowman","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"key20210921224256_JCTH-D-21-00171-b5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"11","key":"key20210921224256_JCTH-D-21-00171-b6","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","article-title":"The global NAFLD epidemic","volume":"10","author":"Loomba","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"key20210921224256_JCTH-D-21-00171-b7","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"key20210921224256_JCTH-D-21-00171-b8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD","volume":"63","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"key20210921224256_JCTH-D-21-00171-b9","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/ijms17040562","article-title":"NAFLD and chronic kidney disease","volume":"17","author":"Marcuccilli","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"2","key":"key20210921224256_JCTH-D-21-00171-b10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nrneph.2016.163","article-title":"The global burden of chronic kidney disease: estimates, variability and pitfalls","volume":"13","author":"Glassock","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"key20210921224256_JCTH-D-21-00171-b11","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2014.05.019","article-title":"CKD and nonalcoholic fatty liver disease","volume":"64","author":"Targher","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"key20210921224256_JCTH-D-21-00171-b12","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease","volume":"59","author":"Armstrong","year":"2014","journal-title":"Hepatology"},{"issue":"4-5","key":"key20210921224256_JCTH-D-21-00171-b13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000350158","article-title":"Chronic kidney disease and nonalcoholic Fatty liver disease proven by transient elastography","volume":"37","author":"Mikolasevic","year":"2013","journal-title":"Kidney Blood Press Res"},{"issue":"2","key":"key20210921224256_JCTH-D-21-00171-b14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s12072-015-9690-5","article-title":"High FIB-4 index as an independent risk factor of prevalent chronic kidney disease in patients with nonalcoholic fatty liver disease","volume":"10","author":"Xu","year":"2016","journal-title":"Hepatol Int"},{"issue":"6","key":"key20210921224256_JCTH-D-21-00171-b15","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2337\/dc13-2704","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes","volume":"37","author":"Targher","year":"2014","journal-title":"Diabetes Care"},{"issue":"5","key":"key20210921224256_JCTH-D-21-00171-b16","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1159\/000343885","article-title":"Association between nonalcoholic liver disease and chronic kidney disease: an ultrasound analysis from NHANES 1988-1994","volume":"36","author":"Sirota","year":"2012","journal-title":"Am J Nephrol"},{"issue":"5","key":"key20210921224256_JCTH-D-21-00171-b17","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jhep.2010.11.007","article-title":"Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link?","volume":"54","author":"Targher","year":"2011","journal-title":"J Hepatol"},{"issue":"3","key":"key20210921224256_JCTH-D-21-00171-b18","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00125-007-0897-4","article-title":"Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative\/laser-treated retinopathy in type 2 diabetic patients","volume":"51","author":"Targher","year":"2008","journal-title":"Diabetologia"},{"issue":"7","key":"key20210921224256_JCTH-D-21-00171-b19","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00125-010-1720-1","article-title":"Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients","volume":"53","author":"Targher","year":"2010","journal-title":"Diabetologia"},{"issue":"2","key":"key20210921224256_JCTH-D-21-00171-b20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1464-5491.2011.03427.x","article-title":"Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non-alcoholic fatty liver","volume":"29","author":"Targher","year":"2012","journal-title":"Diabet Med"},{"issue":"12","key":"key20210921224256_JCTH-D-21-00171-b21","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.2215\/CJN.05050610","article-title":"Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis","volume":"5","author":"Targher","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"key20210921224256_JCTH-D-21-00171-b22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4082\/kjfm.2013.34.3.199","article-title":"Non-alcoholic fatty liver disease and chronic kidney disease in Koreans aged 50 years or older","volume":"34","author":"Ahn","year":"2013","journal-title":"Korean J Fam Med"},{"issue":"4","key":"key20210921224256_JCTH-D-21-00171-b23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/1751-2980.12465","article-title":"Association between non-invasively diagnosed hepatic steatosis and chronic kidney disease in Chinese adults on their health check-up","volume":"18","author":"Zeng","year":"2017","journal-title":"J Dig Dis"},{"issue":"4","key":"key20210921224256_JCTH-D-21-00171-b24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/MEG.0000000000000531","article-title":"Nonalcoholic fatty liver is not associated with incident chronic kidney disease: a large histology-based comparison with healthy individuals","volume":"28","author":"Choudhary","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"key20210921224256_JCTH-D-21-00171-b25","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1681\/ASN.2007101155","article-title":"Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease","volume":"19","author":"Targher","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"key20210921224256_JCTH-D-21-00171-b26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jhep.2020.03.003","article-title":"Incidence of chronic kidney disease in patients with non-alcoholic fatty liver disease","volume":"73","author":"Zou","year":"2020","journal-title":"J Hepatol"},{"issue":"8","key":"key20210921224256_JCTH-D-21-00171-b27","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/liv.14125","article-title":"Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: a secondary analysis","volume":"39","author":"Wilechansky","year":"2019","journal-title":"Liver Int"},{"issue":"1","key":"key20210921224256_JCTH-D-21-00171-b28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12876-020-01278-z","article-title":"Association between NAFLD and risk of prevalent chronic kidney disease: why there is a difference between east and west?","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"key20210921224256_JCTH-D-21-00171-b29","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jhep.2017.08.024","article-title":"Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: a cohort study","volume":"67","author":"Sinn","year":"2017","journal-title":"J Hepatol"},{"issue":"6","key":"key20210921224256_JCTH-D-21-00171-b30","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/joim.12964","article-title":"Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study","volume":"286","author":"Park","year":"2019","journal-title":"J Intern Med"},{"key":"key20210921224256_JCTH-D-21-00171-b31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.metabol.2017.11.003","article-title":"Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic review and meta-analysis","volume":"79","author":"Mantovani","year":"2018","journal-title":"Metabolism"},{"issue":"1 Pt 1","key":"key20210921224256_JCTH-D-21-00171-b32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jfma.2019.02.010","article-title":"The correlation between fatty liver disease and chronic kidney disease","volume":"119","author":"Chen","year":"2020","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"key20210921224256_JCTH-D-21-00171-b33","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1038\/s41598-018-23014-0","article-title":"Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study","volume":"8","author":"Jang","year":"2018","journal-title":"Sci Rep"},{"issue":"7","key":"key20210921224256_JCTH-D-21-00171-b34","doi-asserted-by":"crossref","first-page":"e1001680","DOI":"10.1371\/journal.pmed.1001680","article-title":"Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis","volume":"11","author":"Musso","year":"2014","journal-title":"PLoS Med"},{"issue":"1","key":"key20210921224256_JCTH-D-21-00171-b35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1874303X02013010001","article-title":"Correlation between non-alcoholic fatty liver and chronic kidney disease","volume":"13","author":"Kasim","year":"2020","journal-title":"Open Urol Nephrol J"},{"issue":"10","key":"key20210921224256_JCTH-D-21-00171-b36","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2169\/internalmedicine.50.5043","article-title":"The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease","volume":"50","author":"Arase","year":"2011","journal-title":"Intern Med"},{"issue":"7","key":"key20210921224256_JCTH-D-21-00171-b37","doi-asserted-by":"crossref","first-page":"611","DOI":"10.5152\/tjg.2019.18343","article-title":"Association of obesity with chronic kidney disease in elderly patients with nonalcoholic fatty liver disease","volume":"30","author":"Luo","year":"2019","journal-title":"Turk J Gastroenterol"},{"issue":"4","key":"key20210921224256_JCTH-D-21-00171-b38","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/MEG.0000000000001045","article-title":"Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA","volume":"30","author":"Wijarnpreecha","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"key20210921224256_JCTH-D-21-00171-b39","doi-asserted-by":"crossref","first-page":"e88569","DOI":"10.1371\/journal.pone.0088569","article-title":"Association between noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver disease","volume":"9","author":"Sesti","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"key20210921224256_JCTH-D-21-00171-b40","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.metabol.2010.07.022","article-title":"Nonalcoholic steatohepatitis and increased risk of chronic kidney disease","volume":"60","author":"Yasui","year":"2011","journal-title":"Metabolism"},{"issue":"7","key":"key20210921224256_JCTH-D-21-00171-b41","doi-asserted-by":"crossref","first-page":"e0180951","DOI":"10.1371\/journal.pone.0180951","article-title":"The fatty liver index as a predictor of incident chronic kidney disease in a 10-year prospective cohort study","volume":"12","author":"Huh","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"key20210921224256_JCTH-D-21-00171-b42","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.metabol.2007.11.022","article-title":"Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men","volume":"57","author":"Chang","year":"2008","journal-title":"Metabolism"},{"issue":"2","key":"key20210921224256_JCTH-D-21-00171-b43","doi-asserted-by":"crossref","first-page":"e18626","DOI":"10.1097\/MD.0000000000018626","article-title":"Urinary fatty acid and retinol binding protein-4 predict CKD progression in severe NAFLD patients with hypertension: 4-year study with clinical and experimental approaches","volume":"99","author":"Tsai","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"key20210921224256_JCTH-D-21-00171-b44","doi-asserted-by":"crossref","first-page":"154433","DOI":"10.1016\/j.metabol.2020.154433","article-title":"MAFLD and risk of CKD","volume":"115","author":"Sun","year":"2021","journal-title":"Metabolism"},{"issue":"4","key":"key20210921224256_JCTH-D-21-00171-b45","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-0028-1091978","article-title":"The epidemiology of nonalcoholic fatty liver disease: a global perspective","volume":"28","author":"Lazo","year":"2008","journal-title":"Semin Liver Dis"},{"issue":"1","key":"key20210921224256_JCTH-D-21-00171-b46","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus","volume":"14","author":"Tilg","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"key20210921224256_JCTH-D-21-00171-b47","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/gutjnl-2020-322572","article-title":"Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals","volume":"70","author":"Mantovani","year":"2021","journal-title":"Gut"},{"issue":"13","key":"key20210921224256_JCTH-D-21-00171-b48","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management: a review","volume":"322","author":"Chen","year":"2019","journal-title":"JAMA"},{"issue":"23","key":"key20210921224256_JCTH-D-21-00171-b49","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1001\/jama.1997.03550230045035","article-title":"Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple risk factor intervention trial","volume":"278","author":"Brancati","year":"1997","journal-title":"JAMA"},{"issue":"7","key":"key20210921224256_JCTH-D-21-00171-b50","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"issue":"4","key":"key20210921224256_JCTH-D-21-00171-b51","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/HJH.0000000000001245","article-title":"Association between MRI-derived hepatic fat fraction and blood pressure in participants without history of cardiovascular disease","volume":"35","author":"Lorbeer","year":"2017","journal-title":"J Hypertens"},{"issue":"2","key":"key20210921224256_JCTH-D-21-00171-b52","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jhep.2016.09.022","article-title":"Bi-directional analysis between fatty liver and cardiovascular disease risk factors","volume":"66","author":"Ma","year":"2017","journal-title":"J Hepatol"},{"issue":"19","key":"key20210921224256_JCTH-D-21-00171-b53","doi-asserted-by":"crossref","first-page":"e842","DOI":"10.1097\/MD.0000000000000842","article-title":"Increased levels of systolic blood pressure within the normal range are associated with significantly elevated risks of nonalcoholic fatty liver disease","volume":"94","author":"Wu","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"key20210921224256_JCTH-D-21-00171-b54","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2478\/jtim-2020-0033","article-title":"Pathogenesis and damage targets of hypertensive kidney injury","volume":"8","author":"Sun","year":"2020","journal-title":"J Transl Int Med"},{"issue":"2","key":"key20210921224256_JCTH-D-21-00171-b55","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/jhh.2013.55","article-title":"Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage","volume":"28","author":"Mennuni","year":"2014","journal-title":"J Hum Hypertens"},{"issue":"3","key":"key20210921224256_JCTH-D-21-00171-b56","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s40620-019-00684-1","article-title":"Recent insights into sodium and potassium handling by the aldosterone-sensitive distal nephron: a review of the relevant physiology","volume":"33","author":"Rossi","year":"2020","journal-title":"J Nephrol"},{"issue":"1","key":"key20210921224256_JCTH-D-21-00171-b57","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.ajkd.2018.12.044","article-title":"Hypertension in CKD: core curriculum 2019","volume":"74","author":"Ku","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"key20210921224256_JCTH-D-21-00171-b58","doi-asserted-by":"crossref","first-page":"S408","DOI":"10.1016\/j.ekir.2019.05.1071","article-title":"MON-267 relationship between liver fibrosis and chronic kidney disease in non-alcoholic fatty liver disease subjects","volume":"4","author":"Ramadhan","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"9","key":"key20210921224256_JCTH-D-21-00171-b59","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"key20210921224256_JCTH-D-21-00171-b60","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jceh.2017.12.005","article-title":"Renal dysfunction in patients with nonalcoholic fatty liver disease is related to the presence of diabetes mellitus and severity of liver disease","volume":"9","author":"Nampoothiri","year":"2019","journal-title":"J Clin Exp Hepatol"},{"issue":"2","key":"key20210921224256_JCTH-D-21-00171-b61","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jhep.2020.03.006","article-title":"Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping","volume":"73","author":"Liu","year":"2020","journal-title":"J Hepatol"},{"key":"key20210921224256_JCTH-D-21-00171-b62","article-title":"Weight loss significantly reduces the risk of chronic kidney disease development in patients with non-alcoholic fatty liver disease. The International Liver Congress; 2019 Apr 10-Apr 14; Vienna, Austria. Elsevier; 2019. p. e292-e293","author":"Chon"},{"key":"key20210921224256_JCTH-D-21-00171-b63","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fphar.2016.00159","article-title":"Non-invasive markers of liver fibrosis: adjuncts or alternatives to liver biopsy?","volume":"7","author":"Chin","year":"2016","journal-title":"Front Pharmacol"},{"issue":"2","key":"key20210921224256_JCTH-D-21-00171-b64","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"issue":"4","key":"key20210921224256_JCTH-D-21-00171-b65","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"key20210921224256_JCTH-D-21-00171-b66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"key20210921224256_JCTH-D-21-00171-b67","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/sj.ijo.0800571","article-title":"Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty","volume":"22","author":"Luyckx","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"key":"key20210921224256_JCTH-D-21-00171-b68","article-title":"Urinary neutrophil gelatinase associated lipocalin (NGAL); a new biomarker for predicting chronic kidney disease (CKD) in patients with nonalcoholic fatty liver disease (NAFLD). 29th Annual Conference of Asian Pacific Association for the Study of the Liver; 2020 Mar 04-Mar 08; Bali, Indonesia. Elsevier; 2020. p. s334","author":"Huttakan"},{"key":"key20210921224256_JCTH-D-21-00171-b69","doi-asserted-by":"crossref","first-page":"7659243","DOI":"10.1155\/2018\/7659243","article-title":"Markers of glomerular and tubular damage in the early stage of kidney disease in type 2 diabetic patients","volume":"2018","author":"\u017by\u0142ka","year":"2018","journal-title":"Mediators Inflamm"},{"issue":"6","key":"key20210921224256_JCTH-D-21-00171-b70","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/hep.22896","article-title":"Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease","volume":"49","author":"Milner","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"key20210921224256_JCTH-D-21-00171-b71","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/oby.20233","article-title":"Retinol binding protein-4 circulating levels were higher in nonalcoholic fatty liver disease vs. histologically normal liver from morbidly obese women","volume":"21","author":"Terra","year":"2013","journal-title":"Obesity (Silver Spring, Md)"},{"issue":"2","key":"key20210921224256_JCTH-D-21-00171-b72","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"issue":"2","key":"key20210921224256_JCTH-D-21-00171-b73","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/HJH.0b013e3280112d0e","article-title":"C-reactive protein and intercellular adhesion molecule-1 are stronger predictors of oxidant stress than blood pressure in established hypertension","volume":"25","author":"Cottone","year":"2007","journal-title":"J Hypertens"},{"issue":"12","key":"key20210921224256_JCTH-D-21-00171-b74","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"issue":"6","key":"key20210921224256_JCTH-D-21-00171-b75","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/ng.3855","article-title":"Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci","volume":"49","author":"Stender","year":"2017","journal-title":"Nat Genet"},{"issue":"12","key":"key20210921224256_JCTH-D-21-00171-b76","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa1712191","article-title":"A protein-truncating HSD17B13 variant and protection from chronic liver disease","volume":"378","author":"Abul-Husn","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"key20210921224256_JCTH-D-21-00171-b77","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11695-008-9549-0","article-title":"Nutritional assessments of patients with non-alcoholic fatty liver disease","volume":"20","author":"Kim","year":"2010","journal-title":"Obes Surg"},{"issue":"3","key":"key20210921224256_JCTH-D-21-00171-b78","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jada.2011.10.007","article-title":"The role of diet and nutrient composition in nonalcoholic Fatty liver disease","volume":"112","author":"McCarthy","year":"2012","journal-title":"J Acad Nutr Diet"},{"issue":"10","key":"key20210921224256_JCTH-D-21-00171-b79","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1586\/17474124.2015.1075392","article-title":"The benefits of exercise for patients with non-alcoholic fatty liver disease","volume":"9","author":"Keating","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"9888","key":"key20210921224256_JCTH-D-21-00171-b80","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"key20210921224256_JCTH-D-21-00171-b81","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.semnephrol.2017.02.005","article-title":"Traditional medicines and kidney disease in low- and middle-income countries: opportunities and challenges","volume":"37","author":"Stanifer","year":"2017","journal-title":"Semin Nephrol"},{"issue":"7","key":"key20210921224256_JCTH-D-21-00171-b82","doi-asserted-by":"crossref","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease - a systematic review and meta-analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS One"},{"key":"key20210921224256_JCTH-D-21-00171-b83","doi-asserted-by":"crossref","first-page":"847539","DOI":"10.1155\/2014\/847539","article-title":"Chronic kidney disease and nonalcoholic Fatty liver disease-is there a link?","volume":"2014","author":"Orli\u0107","year":"2014","journal-title":"Gastroenterol Res Pract"},{"issue":"12","key":"key20210921224256_JCTH-D-21-00171-b84","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrneph.2009.173","article-title":"Emerging risk factors and markers of chronic kidney disease progression","volume":"5","author":"Kronenberg","year":"2009","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"key20210921224256_JCTH-D-21-00171-b85","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1556\/2060.106.2019.35","article-title":"A brief review on the rising incidence of chronic kidney diseases and non-alcoholic fatty liver disease","volume":"106","author":"Nagy","year":"2019","journal-title":"Physiol Int"},{"issue":"12","key":"key20210921224256_JCTH-D-21-00171-b86","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1091\/mbc.E15-01-0036","article-title":"CHOP links endoplasmic reticulum stress to NF-\u03baB activation in the pathogenesis of nonalcoholic steatohepatitis","volume":"26","author":"Willy","year":"2015","journal-title":"Mol Biol Cell"},{"issue":"3","key":"key20210921224256_JCTH-D-21-00171-b87","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1681\/ASN.2009080820","article-title":"Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK","volume":"21","author":"Ix","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"key20210921224256_JCTH-D-21-00171-b88","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1525-139X.2009.00590.x","article-title":"The role of oxidative stress in chronic kidney disease","volume":"22","author":"Massy","year":"2009","journal-title":"Semin Dial"},{"issue":"4","key":"key20210921224256_JCTH-D-21-00171-b89","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrneph.2015.206","article-title":"Hurdles to the introduction of new therapies for immune-mediated kidney diseases","volume":"12","author":"Anders","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"key20210921224256_JCTH-D-21-00171-b90","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.molmed.2015.08.005","article-title":"Emerging liver-kidney interactions in nonalcoholic fatty liver disease","volume":"21","author":"Musso","year":"2015","journal-title":"Trends Mol Med"},{"issue":"5","key":"key20210921224256_JCTH-D-21-00171-b91","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S2213-8587(14)70065-8","article-title":"Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease","volume":"2","author":"de Vries","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5907","key":"key20210921224256_JCTH-D-21-00171-b92","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1126\/science.1160794","article-title":"A stress signaling pathway in adipose tissue regulates hepatic insulin resistance","volume":"322","author":"Sabio","year":"2008","journal-title":"Science (New York, NY)"},{"issue":"4","key":"key20210921224256_JCTH-D-21-00171-b93","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0092-8674(89)90098-6","article-title":"Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity","volume":"58","author":"Auberger","year":"1989","journal-title":"Cell"},{"issue":"6","key":"key20210921224256_JCTH-D-21-00171-b94","doi-asserted-by":"crossref","first-page":"F1087","DOI":"10.1152\/ajprenal.00340.2016","article-title":"Insulin resistance in chronic kidney disease: a systematic review","volume":"311","author":"Spoto","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"key20210921224256_JCTH-D-21-00171-b95","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrneph.2017.16","article-title":"Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease","volume":"13","author":"Targher","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"key20210921224256_JCTH-D-21-00171-b96","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/ndt\/gfl204","article-title":"Fetuin-A and kidney function in persons with coronary artery disease\u2014data from the Heart and Soul Study","volume":"21","author":"Ix","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"1 Suppl","key":"key20210921224256_JCTH-D-21-00171-b97","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"issue":"2","key":"key20210921224256_JCTH-D-21-00171-b98","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11906-012-0250-2","article-title":"Lipid nephrotoxicity: new concept for an old disease","volume":"14","author":"Gyebi","year":"2012","journal-title":"Curr Hypertens Rep"},{"issue":"Suppl 1","key":"key20210921224256_JCTH-D-21-00171-b99","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000447276","article-title":"Extrahepatic diseases and NAFLD: the triangular relationship between NAFLD, type 2-diabetes and dysbiosis","volume":"34","author":"Scorletti","year":"2016","journal-title":"Dig Dis"},{"issue":"8335","key":"key20210921224256_JCTH-D-21-00171-b100","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0140-6736(83)92478-9","article-title":"Fermentation in the human large intestine: evidence and implications for health","volume":"1","author":"Cummings","year":"1983","journal-title":"Lancet (London, England)"},{"issue":"9","key":"key20210921224256_JCTH-D-21-00171-b101","doi-asserted-by":"crossref","first-page":"e1007191","DOI":"10.1371\/journal.ppat.1007191","article-title":"Para-cresol production by Clostridium difficile affects microbial diversity and membrane integrity of Gram-negative bacteria","volume":"14","author":"Passmore","year":"2018","journal-title":"PLoS Pathog"},{"key":"key20210921224256_JCTH-D-21-00171-b102","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.trsl.2016.04.007","article-title":"Gut microbiome in chronic kidney disease: challenges and opportunities","volume":"179","author":"Nallu","year":"2017","journal-title":"Transl Res"},{"issue":"7341","key":"key20210921224256_JCTH-D-21-00171-b103","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"issue":"3","key":"key20210921224256_JCTH-D-21-00171-b104","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","article-title":"Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease","volume":"116","author":"Tang","year":"2015","journal-title":"Circ Res"},{"issue":"9972","key":"key20210921224256_JCTH-D-21-00171-b105","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet (London, England)"},{"issue":"3","key":"key20210921224256_JCTH-D-21-00171-b106","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000371679","article-title":"Relationship between obesity, gut microbiome and hepatocellular carcinoma development","volume":"33","author":"Hara","year":"2015","journal-title":"Dig Dis"},{"issue":"9","key":"key20210921224256_JCTH-D-21-00171-b107","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.molmet.2016.06.003","article-title":"Non-alcoholic fatty liver and the gut microbiota","volume":"5","author":"Bashiardes","year":"2016","journal-title":"Mol Metab"},{"issue":"3","key":"key20210921224256_JCTH-D-21-00171-b108","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ijo.2014.153","article-title":"The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents","volume":"39","author":"Psichas","year":"2015","journal-title":"Int J Obes (Lond)"}],"container-title":["Journal of Clinical and Translational Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2021-00171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:20:09Z","timestamp":1783707609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2021-00171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,21]]},"published-print":{"date-parts":[[2022,2,28]]}},"alternative-id":["10.14218\/JCTH.2021.00171"],"URL":"https:\/\/doi.org\/10.14218\/jcth.2021.00171","relation":{},"ISSN":["2225-0719","2310-8819"],"issn-type":[{"value":"2225-0719","type":"print"},{"value":"2310-8819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,22]]}}}